Risk of myocarditis and pericarditis following coronavirus disease 2019 messenger RNA Vaccination—A nationwide study
Open Access
- 8 February 2023
- journal article
- research article
- Published by Elsevier in Journal of Microbiology, Immunology and Infection
- Vol. 56 (3) , 558-565
Abstract
No abstract availableKeywords
All Related Versions
This publication has 10 references indexed in Scilit:
- Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, CanadaJAMA Network Open, 2022
- Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysisThe Lancet Respiratory Medicine, 2022
- Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021JAMA, 2022
- Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in IsraelNew England Journal of Medicine, 2021
- Epidemiology of Acute Myocarditis/Pericarditis in Hong Kong Adolescents Following Comirnaty VaccinationClinical Infectious Diseases, 2021
- Myocarditis With COVID-19 mRNA VaccinesCirculation, 2021
- Self controlled case series methods: an alternative to standard epidemiological study designsBMJ, 2016
- Design of a robust infrastructure to monitor the safety of the pandemic A(H1N1) 2009 vaccination program in TaiwanVaccine, 2010
- Determinants of Under-Reporting of Adverse Drug ReactionsDrug Safety, 2009
- Under-Reporting of Adverse Drug ReactionsDrug Safety, 2006